Department of Polymer Science & Engineering, University of Massachusetts, Amherst, MA 01003, USA.
Chem Commun (Camb). 2010 Mar 7;46(9):1377-93. doi: 10.1039/b920570p. Epub 2010 Jan 28.
Synthetic polymers have transformed society in many areas of science and technology, including recent breakthroughs in medicine. Synthetic polymers now offer unique and versatile platforms for drug delivery, as they can be "bio-tailored" for applications as implants, medical devices, and injectable polymer-drug conjugates. However, while several currently used therapeutic proteins and small molecule drugs have benefited from synthetic polymers, the full potential of polymer-based drug delivery platforms has not yet been realized. This review examines both general advantages and specific cases of synthetic polymers in drug delivery, focusing on PEGylation in the context of polymer architecture, self-assembly, and conjugation techniques that show considerable effectiveness and/or potential in therapeutics.
合成聚合物在科学和技术的许多领域都改变了社会,包括医学的最新突破。合成聚合物现在为药物输送提供了独特而通用的平台,因为它们可以针对植入物、医疗器械和可注射聚合物-药物偶联物等应用进行“生物定制”。然而,尽管目前有几种治疗性蛋白质和小分子药物得益于合成聚合物,但聚合物药物输送平台的全部潜力尚未实现。这篇综述考察了合成聚合物在药物输送中的一般优势和具体案例,重点介绍了聚合物结构、自组装和缀合技术背景下的 PEGylation,这些技术在治疗学中表现出相当大的有效性和/或潜力。